August 7, 2020August 7, 2020
New Patent Filing for QuadraMune Relates to Potential in Aiding Memory

Therapeutics Solutions International has announced filing a new patent covering the memory protective effects of its natural nutritional supplement QuadraMune, as seen in an animal model of ... Read more
August 7, 2020August 7, 2020
Ofatumumab Seen as Superior to Aubagio at Lowering Relapse Rates in Phase 3 Trials

Novartis‘s ofatumumab outperformed Aubagio (teriflunomide) at lowering the frequency of relapses and preventing disability progression among people with relapsing forms of multiple sclerosis ... Read more
August 6, 2020August 6, 2020
MS Patients Show Greater Risk of Infections Before and After Diagnosis, Study Finds

Multiple sclerosis (MS) patients have a greater risk of infections, particularly urinary and kidney infections, around the time of their diagnosis, compared with individuals ... Read more
August 6, 2020August 6, 2020
Donepezil Seen to Aid Cognition, Life Quality for MS Patients in Small Trial

Donepezil — an approved treatment for Alzheimer’s disease — eased cognitive impairment, depression, and improved other quality-of-life measures in multiple sclerosis (MS) patients with mild to moderate disability, ... Read more
August 5, 2020August 5, 2020
Smoking and Epstein-Barr Virus Combine to Raise MS Risk, Study Says

Cigarette smoking and an Epstein–Barr virus infection together represent a significant risk factor for multiple sclerosis (MS), suggesting that at least one path to ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

Columns

Social Clips

June 26, 2018July 3, 2018

1st Patient Enrolled in Study of Electrical Stimulation in Treating Brain Injury

News

A first patient has been enrolled in a single-site trial to evaluate the potential of electrical stimulation, called Electroceutical Therapy, in reducing brain injury, Endonovo Therapeutics, the therapy’s developer, announced. Electroceutical Therapy is a non-invasive and wearable electronic device that uses pulsed ... Read more

New Patent Filing for QuadraMune Relates to Potential in Aiding Memory

Ofatumumab Seen as Superior to Aubagio at Lowering Relapse Rates in Phase 3 Trials

MS Patients Show Greater Risk of Infections Before and After Diagnosis, Study Finds

Donepezil Seen to Aid Cognition, Life Quality for MS Patients in Small Trial

Smoking and Epstein-Barr Virus Combine to Raise MS Risk, Study Says

Smoking and Epstein-Barr Virus Combine to Raise MS Risk, Study Says

Coffee May Help Ease Fatigue in MS Patients With Milder Disability

3 Ways People Respond to Your MS Diagnosis — and 3 Alternatives

UT Doctoral Student Wins NIH Fellowship to Study MS Cognitive Changes

Oral RRMS Therapy Safely Lowers Active Lesions in Phase 2 Trial, Data Show

MS News That Caught My Eye Last Week: Symptom Progression, Lower Urinary Symptoms, Tysabri, IL-17A Protein Study

Subscribe to our mailing list

Regular Exercise Helps Preserve Key Brain Areas, Study Finds

The Mouth That Roared and Roared

Lemtrada and COVID-19: To Treat or Not to Treat?

Order Seen in Motor Skills Affected by MS, With Walking Taking First Hit

Mental Fatigue in MS May Be Due to Poorer Brain Response to Tasks

A Dog’s Love in a World of MS

Lower Urinary Tract Symptoms Should Be Assessed in MS Cases

Healthy Diet May Lower Risk of Relapse After 1st Myelin Attack, Study Suggests

CHI3L1 Protein Levels May Mark Neurologic Disability in PPMS, Study Suggests

Canadian MS Working Group Updates Guidelines for Diagnosis, Treatment

Columns

3 Ways People Respond to Your MS Diagnosis — and 3 Alternatives

MS News That Caught My Eye Last Week: Symptom Progression, Lower Urinary Symptoms, Tysabri, IL-17A Protein Study

The Mouth That Roared and Roared

Lemtrada and COVID-19: To Treat or Not to Treat?

A Dog’s Love in a World of MS

Managing Expectations on Your Wedding Day

MS News That Caught My Eye Last Week: Ketamine, Arbaclofen ER, Bafiertam, UK Health Services

The Joy of Joining the ‘Downton Abbey’ Set

My Cocker Spaniel, Joey, Is My MS Pal

Putting Myself First

‘You Look OK to Me’

MS News That Caught My Eye Last Week: COVID-19 Website, Testing MS Progression, RIS, Alternative Treatments

What Will We Do?

It’s a Matter of Timing and Mic Technique

Can We Be Taught How to Avoid an MS Fall?

Social Clips

1st Patient Enrolled in Study of Electrical Stimulation in Treating Brain Injury

New Patent Filing for QuadraMune Relates to Potential in Aiding Memory

Ofatumumab Seen as Superior to Aubagio at Lowering Relapse Rates in Phase 3 Trials

MS Patients Show Greater Risk of Infections Before and After Diagnosis, Study Finds

Donepezil Seen to Aid Cognition, Life Quality for MS Patients in Small Trial

Smoking and Epstein-Barr Virus Combine to Raise MS Risk, Study Says

Smoking and Epstein-Barr Virus Combine to Raise MS Risk, Study Says

Coffee May Help Ease Fatigue in MS Patients With Milder Disability

3 Ways People Respond to Your MS Diagnosis — and 3 Alternatives

UT Doctoral Student Wins NIH Fellowship to Study MS Cognitive Changes

Oral RRMS Therapy Safely Lowers Active Lesions in Phase 2 Trial, Data Show

MS News That Caught My Eye Last Week: Symptom Progression, Lower Urinary Symptoms, Tysabri, IL-17A Protein Study

Subscribe to our mailing list

Regular Exercise Helps Preserve Key Brain Areas, Study Finds

The Mouth That Roared and Roared

Lemtrada and COVID-19: To Treat or Not to Treat?

Order Seen in Motor Skills Affected by MS, With Walking Taking First Hit

Mental Fatigue in MS May Be Due to Poorer Brain Response to Tasks

A Dog’s Love in a World of MS

Lower Urinary Tract Symptoms Should Be Assessed in MS Cases

Healthy Diet May Lower Risk of Relapse After 1st Myelin Attack, Study Suggests

CHI3L1 Protein Levels May Mark Neurologic Disability in PPMS, Study Suggests

Canadian MS Working Group Updates Guidelines for Diagnosis, Treatment

3 Ways People Respond to Your MS Diagnosis — and 3 Alternatives

MS News That Caught My Eye Last Week: Symptom Progression, Lower Urinary Symptoms, Tysabri, IL-17A Protein Study

The Mouth That Roared and Roared

Lemtrada and COVID-19: To Treat or Not to Treat?

A Dog’s Love in a World of MS

Managing Expectations on Your Wedding Day

MS News That Caught My Eye Last Week: Ketamine, Arbaclofen ER, Bafiertam, UK Health Services

The Joy of Joining the ‘Downton Abbey’ Set

My Cocker Spaniel, Joey, Is My MS Pal

Putting Myself First

‘You Look OK to Me’

MS News That Caught My Eye Last Week: COVID-19 Website, Testing MS Progression, RIS, Alternative Treatments

What Will We Do?

It’s a Matter of Timing and Mic Technique

Can We Be Taught How to Avoid an MS Fall?

10 Mobile Apps for Better Living With MS

4 Ways Ocrevus Can Improve Your Life

Ocrevus Treatment and Side Effects: What’s Important to Know

4 Ways Ocrevus Can Improve Your Life

5 Things to Know About the New MS Drug Ocrevus

9 Drug Approvals That Changed The Future of Medicine

5 Things to Know About the New MS Drug Ocrevus

9 Approved MS Therapies You Should Know About

Ann Romney’s Fight with Multiple Sclerosis

9 Approved MS Therapies You Should Know About

10 Relapsing-Remitting Multiple Sclerosis (RRMS) Therapies

#CMSC16 – MS and Yoga: Author and Instructor Says Ancient Discipline Can Help Patients in Many Ways

#CMSC16 – Country Artist Clay Walker to MS Patients: You’re Going to Be OK

9 Approved MS Therapies You Should Know About

Mike Nace, Editor-in-Chief of Multiple Sclerosis News Today, Reviews Day 1 at #ECTRIMS2015

1st Patient Enrolled in Study of Electrical Stimulation in Treating Brain Injury